Frequently Asked Questions
Find answers to some of the most common queries about the CLSA.
Thank you for reporting any errors/issues/omissions you discover on the Canadian Longitudinal Study on Aging’s new website. Please complete this brief form to share your feedback.
The CLSA COVID-19 Antibody Study studies the impact of COVID-19 among older adults in Canada, a population that has been shown to be at greatest risk for severe outcomes from COVID-19 disease. The study collected blood samples from CLSA participants to estimate levels of immunity among older adults and provide a deeper understanding of some of the factors that affect their experience of the disease.
Find answers to some of the most common queries about the CLSA.
The Canadian Longitudinal Study on Aging (CLSA) is a Canada-wide study that looks at health and aging over a 20-year period. People between the ages of 45 and 85 were recruited between 2010 and 2015 to take part. The study team collects a wide range of information about people’s health as they age, including physical, emotional and social health functioning, as well as the presence of health conditions and diseases. CLSA participants fall into one of two different groups. Some people participate by telephone interview, while others participate in an in-home interview as well as visit a Data Collection Site in their area.
The CLSA is a strategic initiative of the Canadian Institutes of Health Research (CIHR). Support for the study has been provided by the Government of Canada through the CIHR and the Canada Foundation for Innovation, as well as the provincial governments of British Columbia, Alberta, Manitoba, Ontario, Quebec, Nova Scotia and Newfoundland and Labrador.
Additional funding for CLSA sub-studies has been received from the Public Health Agency of Canada (PHAC), the Weston Family Foundation, the Government of Canada’s COVID-19 Immunity Task Force, Juravinski Research Institute, McMaster University, the McMaster Institute for Research on Aging and the Nova Scotia COVID-19 Health Research Coalition.
In order to determine how people age over time, your ongoing involvement in the CLSA is critical. We recognize that as people age, they face situations that have the potential to affect their participation. For that reason, we offer flexible participation, meaning that we provide you with options that accommodate your personal circumstances.
Your participation is very important to us. The CLSA cannot replace participants who joined the study at the start. Choosing not to take part will impact the scientific results. Less information collected by the CLSA over time influences the quality of data available for researchers and decision-makers who develop the health- and social-care policies that affect everyone.
The CLSA is designed as a research platform to address a wide range of research questions related to aging and the factors influencing health outcomes in older adults. Researchers must apply and be approved to access the CLSA data. They must demonstrate that their proposed research aligns with the guiding principles of CLSA data access, including protecting the rights, privacy and consent of participants, safeguarding the confidentiality and security of the data, and using the CLSA research platform optimally for research that benefits all Canadians.
For example, researchers may study: